SCHEMBL8092881

SCHEMBL8092881

CCCO/N=C(/C(=O)Nc1ccc(C(=O)O)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 6/20 0.58
RARB P10826 5/20 0.58
RARG P13631 4/20 0.58
CYP3A4 P08684 4/20 0.58
RARA P10276 3/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
ALDH1A1 P00352 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
TSHR P16473 1/20 0.58
MAPK1 P28482 1/20 0.58
CYP2C19 P33261 1/20 0.58
RXRA P19793 13/20 0.58
RXRB P28702 9/20 0.58
RXRG P48443 9/20 0.58
PGR P06401 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
TBXA2R P21731 1/20 0.53
BLVRB P30043 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6374326 1.00 CYP26A1 (0.58) CYP26A1RARBRARGCYP3A4RARA
SCHEMBL6374323 1.00 CYP26A1 (0.58) CYP26A1RARBRARGCYP3A4RARA
SCHEMBL8100573 0.92 RXRA (0.58) CYP26A1RARBRARGCYP3A4RARA
SCHEMBL2912697 0.92 RXRA (0.58) CYP26A1RARBRARGCYP3A4RARA
SCHEMBL8100802 0.92 RXRA (0.58) CYP26A1RARBRARGCYP3A4RARA
SCHEMBL2910583 0.92 RXRA (0.58) CYP26A1RARBRARGCYP3A4RARA
SCHEMBL8100576 0.92 RXRA (0.58) CYP26A1RARBRARGCYP3A4RARA
SCHEMBL2910115 0.92 RXRA (0.58) CYP26A1RARBRARGCYP3A4RARA
SCHEMBL8100708 0.92 RXRA (0.58) CYP26A1RARBRARGCYP3A4RARA
SCHEMBL2912695 0.92 RXRA (0.58) CYP26A1RARBRARGCYP3A4RARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0661260-B1 New bi-aromatic compounds derived from amides pharmaceutical compositions and cosmetic compositions containing them and their use CIRD GALDERMA (FR) 1997-03-12 EP claimed
US-6051243-A USEFUL IN THE TOPICAL AND SYSTEMIC TREATMENT OF DERMATOLOGICAL CONDITIONS ASSOCIATED WITH A KERATINIZATION DISORDER, DERMATOLOGICAL CONDITIONS (AND THE LIKE) INCLUDING AN INFLAMMATORY AND/OR IMMUNOALLERGIC COMPONENT CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2000-04-18 US disclosed
EP-0661260-B1 New bi-aromatic compounds derived from amides pharmaceutical compositions and cosmetic compositions containing them and their use CIRD GALDERMA (FR) 1997-03-12 EP disclosed
EP-0661260-A1 New bi-aromatic compounds derived from amides pharmaceutical compositions and cosmetic compositions containing them and their use CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1995-07-05 EP disclosed